 | • レポートコード：20QY06-00827 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、イノシンプラノベックスのグローバル市場について種類別（錠剤、シロップ）、用途別（免疫調節、抗ウイルス、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・イノシンプラノベックス市場の概要 ・世界の主要地域別イノシンプラノベックス市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のイノシンプラノベックス市場規模2015-2026：種類別（錠剤、シロップ） ・世界のイノシンプラノベックス市場規模2015-2026：用途別（免疫調節、抗ウイルス、その他） ・イノシンプラノベックスの北米市場規模2015-2020 ・イノシンプラノベックスのヨーロッパ市場規模2015-2020 ・イノシンプラノベックスの中国市場規模2015-2020 ・イノシンプラノベックスの日本市場規模2015-2020 ・イノシンプラノベックスの東南アジア市場規模2015-2020 ・イノシンプラノベックスのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Newport Pharmaceuticals、Gedeon Richter、Mochida、Sanofi、Andrómaco、Yung Shin、Alfasigma S.p.A.、Polfarmex、Sanfer、Meprofarm、Novell Pharmaceutical、Aflofarm） ・イノシンプラノベックスの製造コスト分析 ・販売チャネル、流通業者、顧客 ・イノシンプラノベックスの市場動向・機会・課題 ・調査の結論 |
Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.
The classification of Inosine Pranobex includes Tablet, Syrup, the sales of Tablet are 8.45 million units, with its market share 69.3%. And the sales market share of Syrup is 30.7% in 2017.
Market Analysis and Insights: Global Inosine Pranobex Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Inosine Pranobex market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Inosine Pranobex industry.
Based on our recent survey, we have several different scenarios about the Inosine Pranobex YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 192.9 million in 2019. The market size of Inosine Pranobex will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Inosine Pranobex Scope and Market Size
The global Inosine Pranobex market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Inosine Pranobex market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Inosine Pranobex market is segmented into
Tablet
Syrup
Segment by Application, the Inosine Pranobex market is segmented into
Immunomodulation
Antiviral
Other
The Inosine Pranobex market is analysed and market size information is provided by regions (countries). Segment by Application, the Inosine Pranobex market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Inosine Pranobex Market Share Analysis
Inosine Pranobex market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Inosine Pranobex business, the date to enter into the Inosine Pranobex market, Inosine Pranobex product introduction, recent developments, etc.
The major vendors covered:
Newport Pharmaceuticals
Gedeon Richter
Mochida
Sanofi
Andrómaco
Yung Shin
Alfasigma S.p.A.
Polfarmex
Sanfer
Meprofarm
Novell Pharmaceutical
Aflofarm
1 Inosine Pranobex Market Overview
1.1 Inosine Pranobex Product Scope
1.2 Inosine Pranobex Segment by Type
1.2.1 Global Inosine Pranobex Sales by Type (2020-2026)
1.2.2 Tablet
1.2.3 Syrup
1.3 Inosine Pranobex Segment by Application
1.3.1 Global Inosine Pranobex Sales Comparison by Application (2020-2026)
1.3.2 Immunomodulation
1.3.3 Antiviral
1.3.4 Other
1.4 Inosine Pranobex Market Estimates and Forecasts (2015-2026)
1.4.1 Global Inosine Pranobex Sales Growth Rate (2015-2026)
1.4.2 Global Inosine Pranobex Revenue and Growth Rate (2015-2026)
1.4.3 Global Inosine Pranobex Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Inosine Pranobex Industry Impact
1.5.1 How the Covid-19 is Affecting the Inosine Pranobex Industry
1.5.1.1 Inosine Pranobex Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Inosine Pranobex Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Inosine Pranobex Players to Combat Covid-19 Impact
2 Inosine Pranobex Estimate and Forecast by Region
2.1 Global Inosine Pranobex Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Inosine Pranobex Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Inosine Pranobex Sales Market Share by Region (2015-2020)
2.2.2 Global Inosine Pranobex Revenue Market Share by Region (2015-2020)
2.3 Global Inosine Pranobex Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Inosine Pranobex Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Inosine Pranobex Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Inosine Pranobex Estimates and Projections (2015-2026)
2.4.2 Europe Inosine Pranobex Estimates and Projections (2015-2026)
2.4.3 China Inosine Pranobex Estimates and Projections (2015-2026)
2.4.4 Japan Inosine Pranobex Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Inosine Pranobex Estimates and Projections (2015-2026)
2.4.6 India Inosine Pranobex Estimates and Projections (2015-2026)
3 Global Inosine Pranobex Competition Landscape by Players
3.1 Global Top Inosine Pranobex Players by Sales (2015-2020)
3.2 Global Top Inosine Pranobex Players by Revenue (2015-2020)
3.3 Global Inosine Pranobex Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inosine Pranobex as of 2019)
3.4 Global Inosine Pranobex Average Price by Company (2015-2020)
3.5 Manufacturers Inosine Pranobex Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Inosine Pranobex Players (Opinion Leaders)
4 Global Inosine Pranobex Market Size by Type
4.1 Global Inosine Pranobex Historic Market Review by Type (2015-2020)
4.1.1 Global Inosine Pranobex Sales Market Share by Type (2015-2020)
4.1.2 Global Inosine Pranobex Revenue Market Share by Type (2015-2020)
4.1.3 Global Inosine Pranobex Price by Type (2014-2020)
4.2 Global Inosine Pranobex Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Inosine Pranobex Sales Forecast by Type (2021-2026)
4.2.2 Global Inosine Pranobex Revenue Forecast by Type (2021-2026)
4.2.3 Global Inosine Pranobex Price Forecast by Type (2021-2026)
5 Global Inosine Pranobex Market Size by Application
5.1 Global Inosine Pranobex Historic Market Review by Application (2015-2020)
5.1.1 Global Inosine Pranobex Sales Market Share by Application (2015-2020)
5.1.2 Global Inosine Pranobex Revenue Market Share by Application (2015-2020)
5.1.3 Global Inosine Pranobex Price by Application (2015-2020)
5.2 Global Inosine Pranobex Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Inosine Pranobex Sales Forecast by Application (2021-2026)
5.2.2 Global Inosine Pranobex Revenue Forecast by Application (2021-2026)
5.2.3 Global Inosine Pranobex Price Forecast by Application (2021-2026)
3 North America Inosine Pranobex Market Facts & Figures
3.2 North America Inosine Pranobex Sales Market Share by Company (2015-2020)
3.3 North America Inosine Pranobex Sales Market Share by Type (2015-2020)
3.4 North America Inosine Pranobex Sales Market Share by Application (2015-2020)
4 Europe Inosine Pranobex Market Facts & Figures
4.2 Europe Inosine Pranobex Sales Market Share by Company (2015-2020)
4.3 Europe Inosine Pranobex Sales Market Share by Type (2015-2020)
4.4 Europe Inosine Pranobex Sales Market Share by Application (2015-2020)
5 China Inosine Pranobex Market Facts & Figures
5.2 China Inosine Pranobex Sales Market Share by Company (2015-2020)
5.3 China Inosine Pranobex Sales Market Share by Type (2015-2020)
5.4 China Inosine Pranobex Sales Market Share by Application (2015-2020)
6 Japan Inosine Pranobex Market Facts & Figures
6.2 Japan Inosine Pranobex Sales Market Share by Company (2015-2020)
6.3 Japan Inosine Pranobex Sales Market Share by Type (2015-2020)
6.4 Japan Inosine Pranobex Sales Market Share by Application (2015-2020)
7 Southeast Asia Inosine Pranobex Market Facts & Figures
7.2 Southeast Asia Inosine Pranobex Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Inosine Pranobex Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Inosine Pranobex Sales Market Share by Application (2015-2020)
8 India Inosine Pranobex Market Facts & Figures
8.2 India Inosine Pranobex Sales Market Share by Company (2015-2020)
8.3 India Inosine Pranobex Sales Market Share by Type (2015-2020)
8.4 India Inosine Pranobex Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Inosine Pranobex Business
12.1 Newport Pharmaceuticals
12.1.1 Newport Pharmaceuticals Inosine Pranobex Corporation Information
12.1.2 Newport Pharmaceuticals Inosine Pranobex Business Overview and Total Revenue
12.1.3 Newport Pharmaceuticals Inosine Pranobex Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Newport Pharmaceuticals Inosine Pranobex Products Offered
12.1.5 Newport Pharmaceuticals Recent Development
12.2 Gedeon Richter
12.2.1 Gedeon Richter Inosine Pranobex Corporation Information
12.2.2 Gedeon Richter Inosine Pranobex Business Overview and Total Revenue
12.2.3 Gedeon Richter Inosine Pranobex Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Gedeon Richter Inosine Pranobex Products Offered
12.2.5 Gedeon Richter Recent Development
12.3 Mochida
12.3.1 Mochida Inosine Pranobex Corporation Information
12.3.2 Mochida Inosine Pranobex Business Overview and Total Revenue
12.3.3 Mochida Inosine Pranobex Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mochida Inosine Pranobex Products Offered
12.3.5 Mochida Recent Development
12.4 Sanofi
12.4.1 Sanofi Inosine Pranobex Corporation Information
12.4.2 Sanofi Inosine Pranobex Business Overview and Total Revenue
12.4.3 Sanofi Inosine Pranobex Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi Inosine Pranobex Products Offered
12.4.5 Sanofi Recent Development
12.5 Andrómaco
12.5.1 Andrómaco Inosine Pranobex Corporation Information
12.5.2 Andrómaco Inosine Pranobex Business Overview and Total Revenue
12.5.3 Andrómaco Inosine Pranobex Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Andrómaco Inosine Pranobex Products Offered
12.5.5 Andrómaco Recent Development
12.6 Yung Shin
12.6.1 Yung Shin Inosine Pranobex Corporation Information
12.6.2 Yung Shin Inosine Pranobex Business Overview and Total Revenue
12.6.3 Yung Shin Inosine Pranobex Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Yung Shin Inosine Pranobex Products Offered
12.6.5 Yung Shin Recent Development
12.7 Alfasigma S.p.A.
12.7.1 Alfasigma S.p.A. Inosine Pranobex Corporation Information
12.7.2 Alfasigma S.p.A. Inosine Pranobex Business Overview and Total Revenue
12.7.3 Alfasigma S.p.A. Inosine Pranobex Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Alfasigma S.p.A. Inosine Pranobex Products Offered
12.7.5 Alfasigma S.p.A. Recent Development
12.8 Polfarmex
12.8.1 Polfarmex Inosine Pranobex Corporation Information
12.8.2 Polfarmex Inosine Pranobex Business Overview and Total Revenue
12.8.3 Polfarmex Inosine Pranobex Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Polfarmex Inosine Pranobex Products Offered
12.8.5 Polfarmex Recent Development
12.9 Sanfer
12.9.1 Sanfer Inosine Pranobex Corporation Information
12.9.2 Sanfer Inosine Pranobex Business Overview and Total Revenue
12.9.3 Sanfer Inosine Pranobex Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sanfer Inosine Pranobex Products Offered
12.9.5 Sanfer Recent Development
12.10 Meprofarm
12.10.1 Meprofarm Inosine Pranobex Corporation Information
12.10.2 Meprofarm Inosine Pranobex Business Overview and Total Revenue
12.10.3 Meprofarm Inosine Pranobex Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Meprofarm Inosine Pranobex Products Offered
12.10.5 Meprofarm Recent Development
12.11 Novell Pharmaceutical
12.11.1 Novell Pharmaceutical Inosine Pranobex Corporation Information
12.11.2 Novell Pharmaceutical Inosine Pranobex Business Overview and Total Revenue
12.11.3 Novell Pharmaceutical Inosine Pranobex Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Novell Pharmaceutical Inosine Pranobex Products Offered
12.11.5 Novell Pharmaceutical Recent Development
12.12 Aflofarm
12.12.1 Aflofarm Inosine Pranobex Corporation Information
12.12.2 Aflofarm Inosine Pranobex Business Overview and Total Revenue
12.12.3 Aflofarm Inosine Pranobex Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Aflofarm Inosine Pranobex Products Offered
12.12.5 Aflofarm Recent Development
13 Inosine Pranobex Manufacturing Cost Analysis
13.1 Inosine Pranobex Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Inosine Pranobex
13.4 Inosine Pranobex Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Inosine Pranobex Distributors List
14.3 Inosine Pranobex Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Inosine Pranobex Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Inosine Pranobex Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Inosine Pranobex Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Inosine Pranobex Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Inosine Pranobex Players to Combat Covid-19 Impact
Table 8. Global Market Inosine Pranobex Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Inosine Pranobex Sales (K Units) by Region (2015-2020)
Table 10. Global Inosine Pranobex Sales Market Share by Region (2015-2020)
Table 11. Global Inosine Pranobex Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Inosine Pranobex Revenue Share by Region (2015-2020)
Table 13. Global Inosine Pranobex Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Inosine Pranobex Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Inosine Pranobex Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Inosine Pranobex Revenue Share Forecast by Region (2021-2026)
Table 17. Global Inosine Pranobex (K Units) of Key Companies (2015-2020)
Table 18. Global Inosine Pranobex Sales Share by Company (2015-2020)
Table 19. Global Inosine Pranobex Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Inosine Pranobex Revenue Share by Company (2015-2020)
Table 21. Global Inosine Pranobex by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inosine Pranobex as of 2019)
Table 22. Global Inosine Pranobex Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Inosine Pranobex Manufacturing Sites and Area Served
Table 24. Manufacturers Inosine Pranobex Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Inosine Pranobex Players
Table 27. Global Inosine Pranobex Sales (K Units) by Type (2015-2020)
Table 28. Global Inosine Pranobex Sales Share by Type (2015-2020)
Table 29. Global Inosine Pranobex Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Inosine Pranobex Price (K Units) by Type (2015-2020)
Table 31. Global Inosine Pranobex Sales Share by Type (2021-2026)
Table 32. Global Inosine Pranobex Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Inosine Pranobex Revenue Share by Type (2021-2026)
Table 34. Global Inosine Pranobex Price (K Units) by Type (2021-2026)
Table 35. Global Inosine Pranobex Sales (K Units) by Application (2015-2020)
Table 36. Global Inosine Pranobex Sales Share by Application (2015-2020)
Table 37. Global Inosine Pranobex Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Inosine Pranobex Price (K Units) by Application (2015-2020)
Table 39. Global Inosine Pranobex Sales (K Units) by Application (2021-2026)
Table 40. Global Inosine Pranobex Sales Share by Application (2021-2026)
Table 41. Global Inosine Pranobex Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Inosine Pranobex Revenue Share by Application (2021-2026)
Table 43. Global Inosine Pranobex Price (K Units) by Application (2021-2026)
Table 44. United States Inosine Pranobex Sales (K Units) by Company (2015-2020)
Table 45. United States Inosine Pranobex Sales Market Share by Company (2015-2020)
Table 46. United States Inosine Pranobex Sales (K Units) by Type (2015-2020)
Table 47. United States Inosine Pranobex Sales Market Share by Type (2015-2020)
Table 48. United States Inosine Pranobex Sales (K Units) by Application (2015-2020)
Table 49. United States Inosine Pranobex Sales Market Share by Application (2015-2020)
Table 50. Europe Inosine Pranobex Sales (K Units) by Company (2015-2020)
Table 51. Europe Inosine Pranobex Sales Market Share by Company (2015-2020)
Table 52. Europe Inosine Pranobex Sales (K Units) by Type (2015-2020)
Table 53. Europe Inosine Pranobex Sales Market Share by Type (2015-2020)
Table 54. Europe Inosine Pranobex Sales (K Units) by Application (2015-2020)
Table 55. Europe Inosine Pranobex Sales Market Share by Type (2015-2020)
Table 56. China Inosine Pranobex Sales (K Units) by Company (2015-2020)
Table 57. China Inosine Pranobex Sales Market Share by Company (2015-2020)
Table 58. China Inosine Pranobex Sales (K Units) by Type (2015-2020)
Table 59. China Inosine Pranobex Sales Market Share by Type (2015-2020)
Table 60. China Inosine Pranobex Sales (K Units) by Application (2015-2020)
Table 61. China Inosine Pranobex Sales Market Share by Application (2015-2020)
Table 62. Japan Inosine Pranobex Sales (K Units) by Company (2015-2020)
Table 63. Japan Inosine Pranobex Sales Market Share by Company (2015-2020)
Table 64. Japan Inosine Pranobex Sales (K Units) by Type (2015-2020)
Table 65. Japan Inosine Pranobex Sales Market Share by Type (2015-2020)
Table 66. Japan Inosine Pranobex Sales (K Units) by Application (2015-2020)
Table 67. Japan Inosine Pranobex Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Inosine Pranobex Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Inosine Pranobex Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Inosine Pranobex Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Inosine Pranobex Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Inosine Pranobex Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Inosine Pranobex Sales Market Share by Application (2015-2020)
Table 74. India Inosine Pranobex Sales (K Units) by Company (2015-2020)
Table 75. India Inosine Pranobex Sales Market Share by Company (2015-2020)
Table 76. India Inosine Pranobex Sales (K Units) by Type (2015-2020)
Table 77. India Inosine Pranobex Sales Market Share by Type (2015-2020)
Table 78. India Inosine Pranobex Sales (K Units) by Application (2015-2020)
Table 79. India Inosine Pranobex Sales Market Share by Application (2015-2020)
Table 80. Newport Pharmaceuticals Corporation Information
Table 81. Newport Pharmaceuticals Description and Business Overview
Table 82. Newport Pharmaceuticals Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Newport Pharmaceuticals Inosine Pranobex Product
Table 84. Newport Pharmaceuticals Recent Development
Table 85. Gedeon Richter Corporation Information
Table 86. Gedeon Richter Description and Business Overview
Table 87. Gedeon Richter Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Gedeon Richter Inosine Pranobex Product
Table 89. Gedeon Richter Recent Development
Table 90. Mochida Corporation Information
Table 91. Mochida Description and Business Overview
Table 92. Mochida Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Mochida Inosine Pranobex Product
Table 94. Mochida Recent Development
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Sanofi Inosine Pranobex Product
Table 99. Sanofi Recent Development
Table 100. Andrómaco Corporation Information
Table 101. Andrómaco Description and Business Overview
Table 102. Andrómaco Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Andrómaco Inosine Pranobex Product
Table 104. Andrómaco Recent Development
Table 105. Yung Shin Corporation Information
Table 106. Yung Shin Description and Business Overview
Table 107. Yung Shin Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Yung Shin Inosine Pranobex Product
Table 109. Yung Shin Recent Development
Table 110. Alfasigma S.p.A. Corporation Information
Table 111. Alfasigma S.p.A. Description and Business Overview
Table 112. Alfasigma S.p.A. Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Alfasigma S.p.A. Inosine Pranobex Product
Table 114. Alfasigma S.p.A. Recent Development
Table 115. Polfarmex Corporation Information
Table 116. Polfarmex Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Polfarmex Description and Business Overview
Table 118. Polfarmex Inosine Pranobex Product
Table 119. Polfarmex Recent Development
Table 120. Sanfer Corporation Information
Table 121. Sanfer Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Sanfer Description and Business Overview
Table 123. Sanfer Inosine Pranobex Product
Table 124. Sanfer Recent Development
Table 125. Meprofarm Corporation Information
Table 126. Meprofarm Description and Business Overview
Table 127. Meprofarm Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Meprofarm Inosine Pranobex Product
Table 129. Meprofarm Recent Development
Table 130. Novell Pharmaceutical Corporation Information
Table 131. Novell Pharmaceutical Description and Business Overview
Table 132. Novell Pharmaceutical Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Novell Pharmaceutical Inosine Pranobex Product
Table 134. Novell Pharmaceutical Recent Development
Table . Aflofarm Corporation Information
Table . Aflofarm Description and Business Overview
Table . Aflofarm Inosine Pranobex Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Aflofarm Inosine Pranobex Product
Table . Aflofarm Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Inosine Pranobex Distributors List
Table 143. Inosine Pranobex Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Inosine Pranobex Product Picture
Figure 2. Global Inosine Pranobex Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Inosine Pranobex Market Share by Application in 2020 & 2026
Figure 6. Immunomodulation Examples
Figure 7. Antiviral Examples
Figure 8. Other Examples
Figure 9. Global Inosine Pranobex Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Inosine Pranobex Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Inosine Pranobex Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Inosine Pranobex Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Inosine Pranobex Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Inosine Pranobex Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Inosine Pranobex Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Inosine Pranobex Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Inosine Pranobex Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Inosine Pranobex Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Inosine Pranobex Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Inosine Pranobex Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Inosine Pranobex Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Inosine Pranobex Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Inosine Pranobex Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Inosine Pranobex Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Inosine Pranobex Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Inosine Pranobex Players Market Share by Revenue in Inosine Pranobex 2015 & 2019
Figure 27. Inosine Pranobex Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Inosine Pranobex Revenue Share by Type (2015-2020)
Figure 29. Global Inosine Pranobex Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Inosine Pranobex Revenue Share by Application (2015-2020)
Figure 31. Global Inosine Pranobex Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Inosine Pranobex Sales Market Share by Type in 2019
Figure 33. United States Inosine Pranobex Sales Market Share by Type in 2019
Figure 34. Europe Inosine Pranobex Sales Market Share by Company in 2019
Figure 35. Europe Inosine Pranobex Sales Market Share by Type in 2019
Figure 36. Europe Inosine Pranobex Sales Market Share by Application in 2019
Figure 37. China Inosine Pranobex Sales Market Share by Company in 2019
Figure 38. China Inosine Pranobex Sales Market Share by Type in 2019
Figure 39. China Inosine Pranobex Sales Market Share by Application in 2019
Figure 40. Japan Inosine Pranobex Sales Market Share by Company in 2019
Figure 41. Japan Inosine Pranobex Sales Market Share by Type in 2019
Figure 42. Japan Inosine Pranobex Sales Market Share by Application in 2019
Figure 43. Southeast Asia Inosine Pranobex Sales Market Share by Company in 2019
Figure 44. Southeast Asia Inosine Pranobex Sales Market Share by Type in 2019
Figure 45. Southeast Asia Inosine Pranobex Sales Market Share by Application in 2019
Figure 46. India Inosine Pranobex Sales Market Share by Company in 2019
Figure 47. India Inosine Pranobex Sales Market Share by Type in 2019
Figure 48. India Inosine Pranobex Sales Market Share by Application in 2019
Figure 49. Newport Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Gedeon Richter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Mochida Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Andrómaco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Yung Shin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Alfasigma S.p.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Polfarmex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Sanfer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Meprofarm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Novell Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Aflofarm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of Inosine Pranobex
Figure 63. Manufacturing Process Analysis of Inosine Pranobex
Figure 64. Inosine Pranobex Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
イノシンプラノベックスの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Inosine Pranobex market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.1% in the forecast period of 2020 to 2025 and will expected to reach USD 215.7 million by 2025, from USD 198.4 million in 2019. The Inosine Prano…- 抗ウイルス剤目薬の世界市場レポート2020 Market Analysis and Insights: Global Antiviral Agents EyeDrops Market The global Antiviral Agents EyeDrops market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Antiviral Agents EyeDrops Scope and Market Size T…
- ロラタジンシロップの世界市場レポート2020 Market Analysis and Insights: Global Loratadine Syrup Market The global Loratadine Syrup market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Loratadine Syrup Scope and Market Size The global Loratadine Syrup …
- 高フルクトースコーンシロップの世界市場レポート2020 A recently published report by QY Research titled Global High Fructose Corn Syrup Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides ac…
- 発泡錠の世界市場レポート2020 Effervescent tablets are designed to break in contact with liquid such as water or juice, often causing the tablet to dissolve into a solution. Market Analysis and Insights: Global Effervescent Tablet Market The global Effervescent Tablet market was valued at US$ xx million in 2019 and will reach US…